NIH recently updated its Research, Condition, and Disease Classification (RCDC) system with FY 2020 actual spending data and estimates for FY 2021 and 2022.
“Coronaviruses” is a new category as part of this update. This category covers Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and all types of other coronaviruses. Footnote #28 on the RCDC Categorical Spending page indicates that the FY 2020 actuals include obligations from resources specified for NIH in FY 2020 COVID-19 related emergency supplemental appropriations and funding from FY 2020 annual appropriations. FY 2021 and FY 2022 estimates reflect anticipated use of carryover from FY 2020 COVID-19 supplemental accounts plus support of research activities from annual appropriations.
Several other new categories as part of the FY 2020 update include (in alphabetical order):
- Electronic Nicotine Delivery Systems
- Esophageal Cancer
- Maternal Morbidity and Mortality
- Postural Orthostatic Tachycardia Syndrome
- Social Determinants of Health
- Stomach Cancer
- Wound Healing & Care
For more background on RCDC and the categorization process, please see this NIH Open Mike blog.